Achillion Pharmaceuticals Inc (NASDAQ:ACHN)

2.95
Delayed Data
As of 4:00pm ET
 -0.05 / -1.67%
Today’s Change
2.58
Today|||52-Week Range
5.66
+2.43%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues0.000.0066.1M15.0M
 
 
 
Depreciation And Amortization399.0K489.0K694.0K955.0K
 
 
 
 
 
 
Operating ExpensesGross Income-399.0K-489.0K----
 
 
 
General Expenses59.1M69.6M81.2M79.3M
 
 
 
 
 
Research And Development46.7M54.2M57.2M59.6M
 
 
 
 
 
Total Operating Expenses59.5M70.1M81.9M80.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-59.5M-70.1M-15.7M-65.3M
 
 
 
 
 
Extraordinary Credit0.00--8.9M0.00
 
 
Interest Expense On Debt52.0K37.0K55.0K68.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-58.9M-69.7M-5.7M-62.1M
 
 
 
 
 
Income Taxes0.00-678.0K-640.0K-411.0K
 
 
 
 
Net Income-58.9M-69.0M-5.0M-61.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS94.0M98.4M125.6M136.7M
 
 
 
 
 
Shares To Calculate EPS Diluted94.0M98.4M125.6M136.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.63-$0.70-$0.04-$0.45
 
 
 
 
 
EPS Diluted-$0.63-$0.70-$0.04-$0.45